Cholecystokinin system in striatal-nigral neuronal networks: Infusion of quinolinic acid into rat striatum

[1]  M. Takita,et al.  Time dependent changes in the concentrations of immunoreactives cholecystokinin octapeptide sulfate in rat brain regions after systemic injection of picrotoxin , 1988, Neurochemistry International.

[2]  T. Hökfelt,et al.  Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P. , 1988, European journal of pharmacology.

[3]  T. Yoshikawa,et al.  Dopaminergic agents affected neuronal transmission of cholecystokinin in the rat brain , 1987, Neuropeptides.

[4]  R. J. Boegman,et al.  Neurotoxicity of quinolinate in the rat nucleus basilis magnocellularis , 1987, Brain Research.

[5]  R. Schwarcz,et al.  Intracerebral quinolinic acid injection in the rat: Effects on dopaminergic neurons , 1986, Brain Research.

[6]  Hideko Yamamoto,et al.  Enzyme Immunoassay for Cholecystokinin Octapeptide Sulfate and Its Application , 1986, Journal of neurochemistry.

[7]  N. Goltermann,et al.  The Biosynthesis of Cholecystokinin in Neural Tissue , 1985, Annals of the New York Academy of Sciences.

[8]  J. Rehfeld,et al.  Molecular Forms of Cholecystokinin in the Brain and the Relationship to Neuronal Gastrins a , 1985, Annals of the New York Academy of Sciences.

[9]  H. Takagi,et al.  The occurrence of cholecystokinin-like immunoreactive neurons in the rat neostriatum: light and electron microscopic analysis , 1984, Brain Research.

[10]  M. Tohyama,et al.  Bilateral α-melanocyte stimulating hormonergic fiber system from zona incerta to cerebral cortex: combined retrograde axonal transport and immunohistochemical study , 1984, Brain Research.

[11]  K. Gysling,et al.  Failure of chronic haloperidol treatment to alter levels of cholecystokinin in the rat brain striatum and olfactory tubercle-nucleus accumbens area , 1984, Neuropeptides.

[12]  P. Frey Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment. , 1983, European journal of pharmacology.

[13]  W. Oertel,et al.  Origin of the cholecystokinin-containing fibers in the rat caudatoputamen. , 1982, Science.

[14]  J. Glowinski,et al.  Biochemical investigation on the localization of the cholecystokinin octapeptide in dopaminergic neurons originating from the ventral tegmental area of the rat , 1981, Neuropeptides.

[15]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[16]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[17]  S. Govoni,et al.  Possible interaction between cholecystokinin and dopamine. , 1982, Advances in biochemical psychopharmacology.